In cancer stem cell and animal models, rebecsinib reversed overactive protein splicing of ADAR1 protein that drives cloning capacity and immune evasion by many malignancies.
Doctors at the University of Chicago Medicine have performed the world's first bilateral stem cell transplant on a patient with drug-resistant bilateral mesial temporal lobe epilepsy (MTLE)
The decade-long study investigated the role of standard cancer treatments, such as chemotherapy, radiation, and surgery, in the metastatic spread of cancer.